Surface Oncology, Inc.
SURFDelisted Sep 8, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001718108
Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.
Superinvestors holding SURF, Q2 2023
1 superinvestor reports holding Surface Oncology, Inc. on Form 13F, worth $1.23M in total. Weight is Surface Oncology, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | <0.1% | 1,412,077 | $1.23M | Reduced−74.3% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SURF each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−74.3%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−1.3%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−7.8%)
Q3 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+8.6%)
Q2 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+4.0%)
Q1 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+0.3%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+15.3%)
Q3 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+3.1%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+10.1%)